Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer – results from the prospective multi-center randomized ADEBAR trial
| Author: | Lukas Schwentner, Nadia Harbeck, Susanne Singer, Martin Eichler, Brigitte Rack, Helmut Forstbauer, Arthur Wischnik, Christoph Scholz, Jens Huober, Thomas W. P. Friedl, Tobias Weissenbacher, Kristin Härtl, Marion Kiechle, Wolfgang Janni, Visnja Fink |
|---|---|
| Frontdoor URL | https://opus.bibliothek.uni-augsburg.de/opus4/122819 |
| ISSN: | 0960-9776OPAC |
| Parent Title (English): | The Breast |
| Publisher: | Elsevier BV |
| Place of publication: | Amsterdam |
| Type: | Article |
| Language: | English |
| Year of first Publication: | 2016 |
| Publishing Institution: | Universität Augsburg |
| Release Date: | 2025/07/10 |
| Volume: | 27 |
| First Page: | 69 |
| Last Page: | 77 |
| DOI: | https://doi.org/10.1016/j.breast.2016.03.003 |
| Institutes: | Medizinische Fakultät |
| Medizinische Fakultät / Universitätsklinikum |
